Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Vitiligo treatments are improving but relapses are common.

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Celiac disease can cause skin issues, and a gluten-free diet can help improve them.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Acute wounds heal well, but chronic wounds struggle due to ongoing inflammation and poor tissue repair.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The conclusion is that a new biopsy technique and humidity chamber help study skin mites better and suggest mite overpopulation may cause skin diseases.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Minoxidil helps hair regrowth by stimulating hair follicles and reducing immune responses.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

It's unclear if cell-based therapies from lipoaspirate devices improve clinical outcomes due to inconsistent data.

Filaggrin mutations are linked to atopic dermatitis and help explain how genetics and environment affect the disease.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Demodex folliculitis can occur in HIV patients on HAART, and treatment may involve topical creams or medication changes.

Rosacea is a common skin condition mainly causing facial redness.

Alopecia areata causes sudden hair loss, has no cure, but treatments can help manage symptoms.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Genetic factors affecting skin health and body weight may increase the risk of dermatophytosis.

Baricitinib is a promising treatment for alopecia areata.

Certain immune cells, when activated by specific signals, can encourage hair growth.

Developing human skin has immune cells with memory-like features.